CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-11 | Dorval Allison Chief Financial Officer | Grant or award | +25,000 | 26,106 | ||
| 2019-01-11 | Dorval Allison Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-11-07 | Dorval Allison Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2018-09-19 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −1,500,000 | 6,391,176 | ||
| 2018-09-19 | LEVIN MARK J Director | Other disposition | −1,500,000 | 6,391,176 | ||
| 2018-09-12 | PIERCE GLENN Director | Purchase | +5,000 | $18.44 | $92K | 5,000 |
| 2018-09-10 | GERAGHTY JAMES A Director | Purchase | +3,000 | $19.39 | $58K | 76,588 |
| 2018-08-17 | GERAGHTY JAMES A Director | Purchase | +3,000 | $18.31 | $55K | 73,588 |
| 2018-07-16 | Turenne Andre President & CEO | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2018-06-20 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −1,500,000 | 7,891,176 | ||
| 2018-06-20 | LEVIN MARK J Director | Other disposition | −1,500,000 | 7,891,176 | ||
| 2018-06-14 | PIERCE GLENN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | LEVIN MARK J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | DIXON WENDY L Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-06-14 | KARSEN PERRY A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-04-10 | Ravina Bernard Chief Medical Officer | Sale | −2,451 | $18.38 | $45K | 0 |
| 2018-03-23 | Henderson Jane Sr. V.P. & CFO, Corp. Dev. | Exercise or conversion | +11,200 | $11.97 | $134K | 11,200 |
Page 15 of 19 · 368 trades